A review of microbiota and irritable bowel syndrome: future in therapies

BK Rodiño-Janeiro, M Vicario, C Alonso-Cotoner… - Advances in …, 2018 - Springer
Irritable bowel syndrome (IBS), one of the most frequent digestive disorders, is characterized
by chronic and recurrent abdominal pain and altered bowel habit. The origin seems to be …

Genetically engineered bacterium: Principles, practices, and prospects

Y Liu, J Feng, H Pan, X Zhang, Y Zhang - Frontiers in Microbiology, 2022 - frontiersin.org
Advances in synthetic biology and the clinical application of bacteriotherapy enable the use
of genetically engineered bacteria (GEB) to combat various diseases. GEB act as a small …

Bacteria-mediated intracellular click reaction for drug enrichment and selective apoptosis of drug-resistant tumor cells

Z Gao, E Zhang, H Zhao, S Xia, H Bai… - … Applied Materials & …, 2022 - ACS Publications
Functionalized biocarriers that can perform bio-orthogonal reactions in tumor cells may
provide solutions to overcome the efflux of the chemotherapeutic agent from drug-resistant …

[HTML][HTML] MOTS-C: A promising mitochondrial-derived peptide for therapeutic exploitation

Y Zheng, Z Wei, T Wang - Frontiers in Endocrinology, 2023 - frontiersin.org
Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c) is a mitochondrial-derived peptide
composed of 16 amino acids encoded by the 12S rRNA region of the mitochondrial genome …

Current status of probiotics for prevention and management of gastrointestinal cancers

AA Khan, V Nema, Z Khan - Expert Opinion on Biological Therapy, 2021 - Taylor & Francis
Introduction Gastrointestinal cancers contribute to a significant number of cancer-associated
mortality. The gastrointestinal tract harbors a multitude of microorganisms, known as the …

Directed Evolution of Escherichia coli Nissle 1917 to Utilize Allulose as Sole Carbon Source

B Xu, LH Liu, S Lai, J Chen, S Wu, W Lei, H Lin… - Small …, 2024 - Wiley Online Library
Sugar substitutes are popular due to their akin taste and low calories. However, excessive
use of aspartame and erythritol can have varying effects. While D‐allulose is presently …

Intervening in disease through genetically-modified bacteria

AK Ferreira, LI Mambelli, SY Pillai - Best Practice & Research Clinical …, 2017 - Elsevier
The comprehension of the molecular basis of different diseases is rapidly being dissected as
a consequence of advancing technology. Consequently, proteins with potential therapeutic …

Microbiote et syndrome de l'intestin irritable: que faut-il savoir? Perspectives thérapeutiques

T Bazin - Côlon & Rectum, 2020 - search.proquest.com
Le syndrome de l'intestin irritable (SII) est une maladie complexe composée de sous-
groupes hétérogènes de patients. Les traitements actuels ne sont pas satisfaisants quant à …